<DOC>
	<DOCNO>NCT01464177</DOCNO>
	<brief_summary>Glioblastoma multiforme ( GBM ) common primary brain tumor adult . The treatment comprise maximal safe resection follow radiotherapy chemotherapy . Despite appropriate management , 90 % patient develop relapse progression . After progression , median survival 5.2 month ( Stupp , 2009 ) . The treatment GBM relapse remain investigational . Reirradiation option select case . The objective study compare 2 scheme stereotactic hypofractionated radiotherapy management recurrent GBM .</brief_summary>
	<brief_title>Hypofractionated Stereotactic Radiotherapy Recurrent Glioblastoma Multiforme</brief_title>
	<detailed_description />
	<mesh_term>Glioblastoma</mesh_term>
	<criteria>18 year age old KPS equal great 60 Anatomopathological confirmation GBM Previous RT therapeutic dos At least 5 month end RT course Not candidate surgical resection Patients partial resection resection recurrent GBM allow Patients local progression resection recurrent GBM allow Lesion maximal 150cc volume , define enhance portion contrast enhance MRI Hemoglobin level ( Hb ) equal great 10ng/dl . Blood transfusion correct Hb allow . Important comorbidities Concomitant chemotherapy Contraindication MRI Brainstem glioma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>malignant glioma</keyword>
	<keyword>glioblastoma</keyword>
	<keyword>radiotherapy</keyword>
	<keyword>randomize</keyword>
</DOC>